| 产品名称 | ReVacc Scientific P53F53 | Pseudovirus_RSV Fusion with Luciferase Reporter (VR26 strain) |
|---|---|
| 目录号 | P53F53 |
| 别名 | Pseudovirus_RSV Fusion with Luciferase Reporter (VR26 strain) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| P53F53 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific P53F53 | Pseudovirus_RSV Fusion with Luciferase Reporter (VR26 strain)
品名：Pseudovirus_RSV Fusion with Luciferase Reporter (VR26 strain)
货号：P53F53
品牌：ReVacc Scientific
规格：200 μl; 1000 μl
产品描述
Organism：Human respiratory syncytial virus (RSV) isolate VR26 strain
This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry the full-length fusion (F) protein of Human respiratory syncytial virus (RSV) isolate VR26 strain (UniProtKB/Swiss-Prot: P12568.2). RSV is a respiratory virus with fusion (F) protein as the major target of neutralizing antibodies/vaccine-elicited sera. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signal ~ 10,000-fold higher than uninfected control (cell alone as background in blue). Three known neutralizing mAb (101F) was used to validate its neutralizing activity against this pseudovirus. See picture.
